key: cord-1023143-yhb2jnsa
authors: González-Rubio, Francisca; Ioakeim-Skoufa, Ignatios; Poblador-Plou, Beatriz; Gimeno-Miguel, Antonio; Prados-Torres, Alexandra
title: Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics
date: 2020-08-11
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1190
sha: 74001a1c64beb18f7d2c3cc34ce06317c3fe4719
doc_id: 1023143
cord_uid: yhb2jnsa

nan

M a n u s c r i p t 2 Dear Editor, A possible co-circulation of the influenza virus with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the upcoming 2020-2021 influenza season could generate a particularly challenging situation for patients, clinicians, and public health systems worldwide.

Influenza vaccination plays a vital role in preventing poorer health outcomes in vulnerable populations. This communication aims to raise awareness about the lack of association between influenza vaccination and a higher risk of coronavirus-related severe outcomes. A c c e p t e d M a n u s c r i p t 3 It is essential to ensure a high coverage vaccination rate in the vulnerable population, especially in the elderly, in order to establish herd immunity [7] . Strengthening people´s trust in the effectiveness and security profile of influenza vaccination programs could help in this direction [8] ; this is important, as many people misbelieve that influenza vaccines can often produce severe side effects.

A recent study in Canada, using information from seven influenza seasons (2010-2017), reported that vaccination was protective against influenza-like illness when the aetiological agent was an influenza virus; in cases of a non-influenza virus, including coronaviruses, there was no positive neither negative effect [9] . The authors concluded that influenza vaccination did not negatively affect seasonal coronavirus risk. In the PRECOVID study, conducted in Spain during the ongoing pandemics, including all the 4412 laboratory-confirmed covid-19 patients of the Aragon region, we found that influenza vaccination was not associated with a higher likelihood of mortality, in men (age-adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 0.95-1.61) and women (OR, 1.23; 95% CI, 0.94-1.61) [10] .

To the best of our knowledge, there is no evidence to associate influenza vaccination with poorer prognosis in covid-19 patients. Efforts should be made to mitigate preventable risks during the upcoming 2020-2021 influenza season. We strongly encourage healthcare professionals to follow the recommendations of the WHO regarding influenza vaccination. 

Accessed 15

Who Needs a Flu Vaccine and When

World Health Organization, Regional Office for Europe. 2019-2020 influenza season: repurposing surveillance systems for COVID-19

COVID-19 and flu, a perfect storm

Routine vaccination during covid-19 pandemic response

World Health Organization. Fifty-sixth World Health Assembly. Prevention and control of influenza pandemics and annual epidemics

Vaccine hesitancy: Definition, scope and determinants

Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada

Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain

The authors sincerely thank all professionals from EpiChron Research Group, Dirección General de Asistencia Sanitaria, Dirección General de Salud Pública, and Servicio Aragonés de Salud (SALUD), from Departamento de Salud del Gobierno de Aragón, for their essential collaboration to advance this research line in the midst of such challenging times.

This work was funded by Gobierno de Aragón (Grant numbers B01_20R and PI20/226) and the European Regional Development Fund "Construyendo Europa desde Aragón".

The authors declare that they have no conflict of interest.A c c e p t e d M a n u s c r i p t